Apprentice.io Raises $24M in Series B Funding
Summary
Apprentice.io, a Jersey City, N.J.-based intelligent software company for life science manufacturing that is helping to increase the speed to market on a number of COVID-19 vaccines, raised $24M in Series B funding. Led by Angelo Stracquatanio, CEO & Co-Founder, Apprentice.io delivers a life science industry’s intelligent manufacturing execution system that helps teams scale faster – from COVID to cancer. From small and large molecule to cell and gene therapy, its cloud-based system leverages artificial intelligence, augmented reality and Pharma 4.0 to increase an organization’s speed to market. The Apprentice System is a dynamic, end-to-end platform with a suite of intelligent software applications designed to streamline batch-based manufacturing and remote collaboration. Solutions include intelligent batch execution, augmented procedures/workflows, predictive resource management, event tracking, remote collaboration and immersive training.
Funding
Review available funding amount, funding date, investors, and linked company information related to Apprentice.io Raises $24M in Series B Funding in the interactive ISVWorld profile.